FTSE 100 movers: AstraZeneca slides on bid rejection
19th May 2014 15:20
Pharmaceutical giant AstraZeneca slumped after it rejected a 'final proposal' from US rival Pfizer. The offer, which valued the London-listed group at £69bn, would not be increased any further, Pfizer said, adding that it would not pursue a hostile offer and would only announce another offer with t
Read moreSector movers: AstraZeneca drags pharma stocks lower on Pfizer drama
19th May 2014 13:52
The pharmaceutical sector was dragged into the red on Monday as shares in AstraZeneca were hit by the news that the board has rejected another offer from US rival Pfizer. AstraZeneca was trading 11.5% lower at 4,270p after turning down a sweetened 5,500p-a-share bid from Pfizer. The new offer, wh
Read moreLondon midday: China slowdown fears hit stocks, AstraZeneca sinks
19th May 2014 11:26
- AstraZeneca drops after rejecting 'final proposal' from Pfizer - Chinese housing concerns weigh on sentiment - Carney comments, Ukraine elections in focus techMARK 2,710.83 -1.26% FTSE 100 6,827.22 -0.42% FTSE 250 15,427.14 +0.19% UK stocks were firmly in the red on Monday as investors kicked of
Read moreCarnegie still sees upside for AstraZeneca even without Pfizer deal
19th May 2014 10:05
Broker Carnegie said it still sees upside in AstraZeneca's share price despite a takeover by Pfizer now looking unlikely. AstraZeneca's shares fell as much as 14% on Monday morning after the board rejected a sweetened £55-a-share bid from Pfizer. The new offer is thought to value AstraZeneca at a
Read moreLondon open: AstraZeneca leads markets lower as shares sink
19th May 2014 08:33
- AstraZeneca drops sharply after rejecting Pfizer offer - Banking, mining stocks fall - China property concerns weigh on sentiment techMARK 2,714.40 -1.13% FTSE 100 6,823.23 -0.48% FTSE 250 15,475.65 +0.50% UK stocks fell on Monday morning with AstraZeneca leading the decline after rejecting a fi
Read moreLondon pre-open: Ukraine elections and BoE remarks in focus
19th May 2014 07:40
Stocks are set to begin this week little changed from the end of last, with just a modest decline of around seven points below Friday's close of 6,855.81. Investors will kick off today's session with AstraZeneca firmly in focus after its board rejected a final offer from US pharmaceutical rival Pfi
Read moreMonday newspaper round-up: Mark Carney, Petroleum reserves, AstraZeneca
19th May 2014 07:25
The government's Help to Buy scheme could distort the entire mortgage market and may have to be curbed, the Governor of the Bank of England warned yesterday. Mark Carney said that the programme to help new home owners to secure a mortgage with a deposit of as little as 5 per cent may be encouraging
Read moreAstraZeneca rejects Pfizer's last-ditch offer
19th May 2014 07:13
AstraZeneca's board has rejected a final offer from US pharmaceutical rival Pfizer, saying the new proposal still undervalues the company and would present 'significant risks for shareholders'. Pfizer lifted its cash-and-shares bid to £55 a share, up from the previous £50-a-share offer made on May
Read morePfizer makes 'final proposal' for AstraZeneca
19th May 2014 06:50
- Offer raised to 55 pounds a share - Pfizer calls on Astra to begin substantive engagement - 'Time for constructive engagement is running out' Pfizer has sweetened its offer for AstraZeneca again in what is thought to be a last-ditch attempt to take over the UK pharmaceutical rival. The US group
Read moreSunday newspaper round-up: AstraZeneca, Carney and housing, M&S
18th May 2014 10:57
Pfizer is weighing up a last-minute improvement to its indicative offer for AstraZeneca, the Sunday Times said. Pfizer is expected to increase the cash portion of its offer and could also increase the price per share before the May 26th deadline to secure a deal. It is also in talks with the Governm
Read moreAstrazeneca upbeat on latest oncology developments
15th May 2014 07:56
AstraZeneca has said its cancer pipeline 'has the potential to redefine the way that cancer patients are treated' as it provided updates on several drug candidates ahead of an industry conference. The FTSE 100 company issued a statement ahead of the 50th Annual Meeting of the American Society of Cl
Read moreThursday newspaper round-up: Exporters, Pfizer, Saudi Arabia
15th May 2014 07:24
Growing confidence among Britain's army of exporters has fuelled hopes that the government can meet its ambitious target of doubling overseas sales to 1trn pounds by 2020. In their latest health check of the sector, the British Chambers of Commerce and DHL Express found that 71 per cent expected tur
Read moreFTSE 100 movers: Aggreko lifted by Citigroup note
14th May 2014 15:15
Aggreko rose strongly today after Citigroup reiterated its 'buy' rating on the stock. Paper and packaging group Mondi was following close behind after it delivered a 13% increase in underlying operating profits in the first quarter despite a "mixed" trading environment and flat sales volumes. Under
Read morePfizer says AstraZeneca deal could help save lives
14th May 2014 12:27
US drugmaker Pfizer on Wednesday defended its proposed takeover of British firm AstraZeneca, saying it could lead to a 'better outcome' for patients. Head of research and development Mikael Dolsten told MPs that merging the two businesses could help prolong the lives of cancer patients despite admi
Read moreAstraZeneca partners Incyte for immunotherapy cancer treatment trial
14th May 2014 07:44
- Tie-up with Incyte to evaluate drug combination - Focused on immunotherapy cancer treatment - Equally co-funding study MedImmune, the biologics research and development arm of AstraZeneca, has entered into a clinical study collaboration with biopharmaceutical company Incyte Corporation. The stud
Read more